Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DEVERGIE A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 74 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rocha, V; Carmagnat, MV; Chevret, S; Flinois, O; Bittencourt, H; Esperou, H; Garnier, F; Ribaud, P; Devergie, A; Socie, G; Dal'Cortivo, L; Marolleau, JP; Charron, D; Gluckman, E; Rabian, C
      Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants

      EXPERIMENTAL HEMATOLOGY
    2. Morariu-Zamfir, R; Rocha, V; Devergie, A; Socie, G; Ribaud, P; Esperou, H; Parquet, N; Guardiola, P; Dal Cortivo, L; Bittencourt, H; Garnier, F; Traineau, R; Marolleau, JP; Chevret, S; Gluckman, E
      Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

      BONE MARROW TRANSPLANTATION
    3. Daneshpouy, M; Socie, G; Clavel, C; Devergie, A; Rivet, J; Cartier, I; Brousse, N; Birembaut, P; Gluckman, E; Janin, A
      Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients

      TRANSPLANTATION
    4. Socie, G; Mary, JY; Esperou, H; Robert, DV; Aractingi, S; Ribaud, P; Devergie, A; Toubert, ME; Boudou, P; Cathelinau, B; Gluckman, E; Vexiau, P
      Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    5. Chen, Y; Rocha, V; Bittencourt, H; Scieux, C; Loiseau, P; Esperou, H; Devergie, A; Guardiola, P; Socle, G; Chevret, S; Charron, D; Gluckman, E; Ribaud, P
      Relationship between HLA alleles and cytomegalovirus infection after allogeneic hematopoietic stem cell transplant

      BLOOD
    6. Socie, G; Clift, RA; Blaise, D; Devergie, A; Ringden, O; Martin, PJ; Remberger, M; Deeg, HJ; Ruutu, T; Michallet, M; Sullivan, KM; Chevret, S
      Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

      BLOOD
    7. Blaise, D; Maraninchi, D; Michallet, M; Reiffers, J; Jouet, JP; Milpied, N; Devergie, A; Attal, M; Sotto, JJ; Kuentz, M; Ifrah, N; Duriac, C; Bordigoni, P; Gratecos, N; Guilhot, F; Guyotat, D; Gluckman, E; Vernant, JP
      Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

      BLOOD
    8. Chen, Y; Scieux, C; Garrait, V; Socie, G; Rocha, V; Molina, JM; Thouvenot, D; Morfin, F; Hocqueloux, L; Garderet, L; Esperou, H; Selimi, F; Devergie, A; Leleu, G; Aymard, M; Morinet, F; Gluckman, E; Ribaud, P
      Resistant herpes simplex virus type 1 infection: An emerging concern afterallogeneic stem cell transplantation

      CLINICAL INFECTIOUS DISEASES
    9. Yakoub-Agha, I; Damaj, G; Garderet, L; Bonnet, J; Devergie, A; Esperou, H; Ribaud, P; Socie, G; Gluckman, E
      Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia

      BONE MARROW TRANSPLANTATION
    10. Parquet, N; Reigneau, O; Humbert, H; Guignard, M; Ribaud, P; Socie, G; Devergie, A; Esperou, H; Gluckman, E
      New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    11. Bellucci, S; Damaj, G; Boval, B; Rocha, V; Devergie, A; Agha, IY; Garderet, L; Ribaud, P; Traineau, R; Socie, G; Gluckman, E
      Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization

      BONE MARROW TRANSPLANTATION
    12. de Witte, T; Hermans, J; Vossen, J; Bacigalupo, A; Meloni, G; Jacobsen, N; Ruutu, T; Ljungman, P; Gratwohl, A; Runde, V; Niederwieser, D; van Biezen, A; Devergie, A; Cornelissen, J; Jouet, JP; Arnold, R; Apperley, J
      Haematopoietic stem cell transplantation for patients with myelodysplasticsyndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

      BRITISH JOURNAL OF HAEMATOLOGY
    13. Guglielmi, C; Arcese, W; Hermans, J; Bacigalupo, A; Bandini, G; Bunjes, D; Carreras, E; Devergie, A; Frassoni, F; Goldman, J; Gratwohl, A; Kolb, HJ; Iori, AP; Niederwieser, D; Prentice, HG; de Witte, E; Apperley, J
      Risk assessment in patients with Ph+ chronic myelogenous leukemia at firstrelapse after allogeneic stem cell transplant: an EBMT retrospective analysis

      BLOOD
    14. Ribaud, P; Chastang, C; Latge, JP; Baffroy-Lafitte, L; Parquet, N; Devergie, A; Esperou, H; Selimi, F; Rocha, V; Derouin, F; Socie, G; Gluckman, E
      Survival and prognostic factors of invasive aspergillosis after allogeneicbone marrow transplantation

      CLINICAL INFECTIOUS DISEASES
    15. Bemba, M; Guardiola, P; Garderet, L; Devergie, A; Ribaud, P; Esperou, H; Noguera, MH; Gluckman, E; Socie, G
      Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria

      BRITISH JOURNAL OF HAEMATOLOGY
    16. SOCIE G; CAYUELA JM; RAYNAL B; ESPEROU H; FUND X; RAFFOUX C; DEVERGIE A; RIBAUD P; MAROLLEAU JP; PARQUET N; SIGAUX F; BRISON O; GLUCKMAN E
      INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION

      Leukemia
    17. GADANO A; HADENGUE A; DEVERGIE A; DENIE C; MOREAU R; DEGOTT C; VALLA D; ERLINGER S; GLUCKMAN E; LEBREC D
      LACK OF EFFECTS OF PROSTAGLANDIN E-1 ON HEPATIC BLOOD-FLOW IN HUMAN

      Hepatology
    18. MEIGNIN V; GLUCKMAN E; GAMBARAELLI D; DEVERGIE A; RAMEE MP; JANIN A; SOCIE G
      MENINGIOMA IN LONG-TERM SURVIVORS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    19. SOCIE G; DEVERGIE A; GIRINSKI T; PIEL G; RIBAUD P; ESPEROU H; PARQUET N; BRISON O; GLUCKMAN E
      TRANSPLANTATION FOR FANCONIS-ANEMIA (FA) - LONG-TERM FOLLOW-UP OF 50 PATIENTS (PTS) TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING

      Bone marrow transplantation
    20. DEVERGIE A; PARQUET N; GARDERET L; ESPEROU H; SOCIE G; RIBAUD P; GLUCKMAN E
      ADVANTAGES OF GENO IDENTICAL BMT WITH A NON TOXIC CONDITIONING REGIMEN AS FIRST LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA

      Bone marrow transplantation
    21. TRAINEAU R; SCIEUX C; AGBALIKA F; RIBAUD P; SOCIE G; ESPEROU H; DEVERGIE A; PARQUET N; BENBUNAN M; GLUCKMAN E
      USE OF FILTERED BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS (CMV) INFECTION AFTER ALLOGENEIC MARROW TRANSPLANT

      Bone marrow transplantation
    22. GRATWOHL A; HERMANS J; GOLDMAN JM; ARCESE W; CARRERAS E; DEVERGIE A; FRASSONI F; GAHRTON G; KOLB H; NIEDERWIESER D; RUUTU T; VERNANT JP; DEWITTE T; APPERLEY J
      RISK ASSESSMENT FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA BEFORE ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION

      Lancet
    23. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      Transplantation
    24. ROCHA V; DEVERGIE A; SOCIE G; RIBAUD P; ESPEROU H; PARQUET N; GLUCKMAN E
      UNUSUAL COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA

      British Journal of Haematology
    25. SOCIE G; DEVERGIE A; GIRINSKI T; PIEL G; RIBAUD P; ESPEROU H; PARQUET N; MAAREK O; NOGUERA MH; RICHARD P; BRISON O; GLUCKMAN E
      TRANSPLANTATION FOR FANCONI ANEMIA - LONG-TERM FOLLOW-UP OF 50 PATIENTS TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING

      British Journal of Haematology
    26. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      British Journal of Haematology
    27. YAKOUBAGHA I; RIBAUD P; DEVERGIE A; GARNIER F; DAMAJ G; ROCHA V; GARDERET L; SELIMI F; GUARDIOLA P; SOCIE G; ESPEROU H; GLUCKMAN E
      BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA (T-MDS) AND ACUTE-LEUKEMIA (T-AL) - EXPERIENCE OF SAINT-LOUIS-HOSPITAL (PARIS)

      British Journal of Haematology
    28. VANRHEE F; SZYDLO RM; HERMANS J; DEVERGIE A; FRASSONI F; ARCESE W; DEWITTE T; KOLB HJ; NIEDERWISER D; JACOBSEN N; GAHRTON G; BANDINI G; CARRERAS E; BACIGALUPO A; MICHALLET M; RUUTU T; REIFFERS J; GOLDMAN JM; APPERLEY J; GRATWOHL A
      LONG-TERM RESULTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - A REPORT FROM THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION

      Bone marrow transplantation
    29. DEVERGIE A; APPERLEY JF; LABOPIN M; MADRIGAL A; JACOBSEN N; CARRERAS E; PRENTICE HG; JOUET JP; KOLB HJ; HERSTENSTEIN B; BACIGALUPO A; EVENSEN SA; LJUNGMAN P; DEWITTE T; REIFFERS J; NAGLER A; CLARK RE; GOLDMAN JM; GRATWOHL A
      EUROPEAN RESULTS OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IMPACT OF HLA CLASS-II MATCHING

      Bone marrow transplantation
    30. BRAUNER R; ADAN L; SOUBERBIELLE JC; ESPEROU H; MICHON J; DEVERGIE A; GLUCKMAN E; ZUCKER JM
      CONTRIBUTION OF GROWTH-HORMONE DEFICIENCY TO THE GROWTH FAILURE THAT FOLLOWS BONE-MARROW TRANSPLANTATION

      The Journal of pediatrics
    31. TOUBERT ME; SOCIE G; GLUCKMAN E; ARACTINGI S; ESPEROU H; DEVERGIE A; RIBAUD P; PARQUET N; SCHLAGETER MH; BERESSI JP; RAIN JD; VEXIAU P
      SHORT-TERM AND LONG-TERM FOLLOW-UP OF THYROID-DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITHOUT THE USE OF PREPARATIVE TOTAL-BODY IRRADIATION

      British Journal of Haematology
    32. RIBAUD P; SCIEUX C; PARQUET N; CARBONNEL E; SOCIE G; EMPEROU H; DEVERGIE A; SELIMI F; GLUCKMAN E
      PRELIMINARY-RESULTS OF CIDOFOVIR (HPMPC) FOR THE TREATMENT OF ADENOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PATIENTS

      Blood
    33. PARQUET N; DEVERGIE A; SOCIE G; RIBAUD P; ESPEROU H; GLUCKMAN E
      VENOOCCLUSIVE DISEASE AFTER BONE-MARROW T RANSPLANTATION - USE OF HEPARIN FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE

      Annales de medecine interne
    34. BACHMEYER C; DEVERGIE A; MANSOURI S; DUBERTRET L; ARACTINGI S
      PYOGENIC GRANULOMA OF THE TONGUE IN CHRON IC GRAFT-VERSUS-HOST DISEASE

      Annales de dermatologie et de venereologie
    35. ARACTINGI S; JANIN A; DEVERGIE A; BOURGES M; SOCIE G; GLUCKMAN E
      HISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY OF DIFFUSE MELANODERMA AFTER BONE-MARROW TRANSPLANTATION

      British journal of dermatology
    36. DEVERGIE A; GIRINSKI T; SOCIE G; GLUCKMAN E
      IMMUNOSUPPRESSIVE TREATMENT WITH 1 GY LYMPHOID IRRADIATION FOR THE TREATMENT OF SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE

      Blood
    37. DEEG HJ; SOCIE G; SCHOCH G; HENRYAMAR M; WITHERSPOON RP; DEVERGIE A; SULLIVAN KM; GLUCKMAN E; STORB R
      MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA AND FANCONI-ANEMIA - A JOINT SEATTLE AND PARIS ANALYSIS OF RESULTS IN 700 PATIENTS

      Blood
    38. SOCIE G; BACIGALUPO A; DEVERGIE A; CAROSELLA E; GLUCKMAN E
      ACQUIRED APLASTIC-ANEMIA - OPTIMUM IMMUNOSUPPRESSIVE TREATMENT

      CLINICAL IMMUNOTHERAPEUTICS
    39. PARQUET N; LEHMAN D; SCIEUX C; DEVERGIE A; MORINET F; GLUCKMAN E
      MONITORING OF CMV INFECTION AND DISEASE AFTER BONE-MARROW TRANSPLANTATION BY CMV ANTIGEN-DETECTION IN PERIPHERAL-BLOOD LEUKOCYTES

      Experimental hematology
    40. PARQUET N; RIBAUD P; CHASTANG C; LATGE JP; SARFATI J; BAFFROYLAFITTE L; DEVERGIE A; ESPEROUBOURDEAU H; TRAORE F; BOUAKLINE A; DEKERVILER E; GLUCKMAN E
      AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS

      Experimental hematology
    41. BERTHEAU P; HADENGUE A; CAZALSHATEM D; DEVERGIE A; SCHENMETZLER C; DEGOS F; ERLINGER S; GLUCKMAN E; DEGOTT C
      CHRONIC CHOLESTASIS IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - SEVERAL DISEASES ARE OFTEN ASSOCIATED

      Bone marrow transplantation
    42. PIGNEUX A; DEVERGIE A; POCHITALOFF M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; JOUET JP; GUILHOT F; GLUCKMAN E; REIFFERS J
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR CHRONIC MYELOGENOUS LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE SOCIETE-FRANCAISE-LE-GREFFE-DE-MOELLE

      Bone marrow transplantation
    43. MOUSSALEM M; BOURDEAU HE; DEVERGIE A; BARUCHEL A; RIBAUD P; SOCIE G; PARQUET N; TRAINEAU R; HIRSCH I; SCHAISON G; GLUCKMAN E
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 2ND REMISSION - FACTORS PREDICTIVE OF SURVIVAL, RELAPSE AND GRAFT-VERSUS-HOST DISEASE

      Bone marrow transplantation
    44. BARGETZI MJ; GLUCKMAN E; TICHELLI A; DEVERGIE A; ESPEROU H; KABATA J; WODNARFILIPOWICZ A; NISSEN C; SPECK B; GRATWOHL A
      RECOMBINANT HUMAN INTERLEUKIN-3 IN REFRACTORY SEVERE APLASTIC-ANEMIA - A PHASE I II TRIAL/

      British Journal of Haematology
    45. GRATWOHL A; HERMANS J; APPERLEY J; ARCESE W; BACIGALUPO A; BANDINI G; DIBARTOLOMEO P; BOOGAERTS M; BOSI A; CARRERAS E; DEVERGIE A; FERRANT A; FIBBE WE; FRASSONI F; GAHRTON G; GOLDMAN J; IRIONDO A; JACOBSEN N; KOLB HJ; LINK H; MICHALLET M; PRENTICE HG; REIFFERS J; VONRHEE F; RUUTU T; SCHWAIGHOFER H; VERNANT JP; DEWITTE T; NIEDERWIESER D
      ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    46. RIBAUD P; CHASTANG CI; LATGE JP; SERFATI J; BAFFROYLAFITTE L; PARQUET N; DEVERGIE A; ESPEROU H; SOCIE G; TRAORE F; BOUAKLINE A; GLUCKMAN E
      INVASIVE ASPERGILLOSIS (IA) AFTER ALLOGENEIC MARROW TRANSPLANTATION -SURVIVAL, PROGNOSTIC FACTORS AND MOLECULAR EPIDEMIOLOGY IN 27 CASES OBSERVED IN A SINGLE-CENTER

      Blood
    47. GLUCKMAN E; TRAINEAU R; BROSSARD U; DALCORTIVO L; DEVERGIE A; RIBAUD P; ESPEROU H; SOCIE G; PARQUET N
      PLACENTAL CORD-BLOOD BANKING AND TRANSPLANT

      Blood
    48. BENASSI T; GIRINSKY T; DEVERGIE A; RAFFOUX C; BEAUDRE A; BRIOT E; BRIDIER A; PICO JL; GLUCKMAN E
      EXPRESSION IN HLA TYPING AT DIFFERENT DOSES OF TOTAL-BODY IRRADIATION

      Blood
    49. DEVERGIE A; BLAISE D; ATTAL M; TIGAUD JD; JOUET JP; VERNANT JP; BORDIGONI P; IFRAH N; DAURIAC C; CAHN JY; LIOURE B; TROUSSARD X; REIFFERS J; GRATECOS N; MILPIED N; BELANGER C; GUYOTAT D; TILLY H; MICHALLET M; GLUCKMAN E
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM)

      Blood
    50. RIO B; CAHN JY; ATTAL M; DROUET L; SCROBOHACI ML; DEGOS F; DEGOTT C; BEARMAN SI; GRANENA A; BLAISE D; DEVERGIE A; BORDIGONI P; IBRAHIM A; DUSURGET C; GORIN NC; FRANCO D; HARTMAN O; GLUCKMAN E
      HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING B ONE-MARROW TRANSPLANTATION - PROCEEDINGS OF A SYMPOSIUM OF FAG AND GEGMO GROUPS

      La Presse medicale
    51. RIBAUD P; ESPEROUBOURDEAU H; DEVERGIE A; GLUCKMAN E
      INVASIVE ASPERGILLOSIS AND ALLOGENEIC BON E-MARROW TRANSPLANTATION

      Pathologie et biologie
    52. DEVERGIE A; LABOPIN M; APPERLEY J; CARRERAS E; PRENTICE G; HERSTENSTEIN B; REIFFERS J; MICHALLET M; JACOBSEN N; JOUET JP; GOLDMAN J; VANBIEZEN A; GRATWOHL A
      MATCHED UNRELATED DONOR (MUD) TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA(CML) IN EUROPE - REPORT OF 299 CASES AND ANALYSIS OF PROGNOSIS FACTORS

      Experimental hematology
    53. MELETIS J; PAPAVASILIOU S; YATAGANAS X; VAVOURAKIS S; KONSTANTOPOULOS K; POZIOPOULOS C; SAMARKOS M; MICHALI E; DALEKOU M; ELIOPOULOS G; LOUKOPOULOS D; DEVERGIE A; GLUCKMAN E
      FETAL ERYTHROPOIESIS FOLLOWING BONE-MARROW TRANSPLANTATION AS ESTIMATED BY THE NUMBER OF F-CELLS IN THE PERIPHERAL-BLOOD

      Bone marrow transplantation
    54. FOOT ABM; GARIN YJF; RIBAUD P; DEVERGIE A; DEROUIN F; GLUCKMAN E
      PROPHYLAXIS OF TOXOPLASMOSIS INFECTION WITH PYRIMETHAMINE SULFADOXINE(FANSIDAR) IN BONE-MARROW TRANSPLANT RECIPIENTS/

      Bone marrow transplantation
    55. PIERGA JY; SOCIE G; GLUCKMAN E; DEVERGIE A; HENRYAMAR M; BRIDIER A; GIRINSKY T; NGUYEN J; COSSET JM
      SECONDARY SOLID MALIGNANT-TUMORS OCCURRING AFTER BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA GIVEN THORACOABDOMINAL IRRADIATION

      Radiotherapy and oncology
    56. SOCIE G; HENRYAMAR M; DEVERGIE A; ESPEROUBOURDEAU H; RIBAUD P; TRAINEAU R; GLUCKMAN E
      MALIGNANT DISEASES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN UPDATED OVERVIEW

      Nouvelle revue francaise d'hematologie
    57. DEVERGIE A; TRAINEAU R; ESPEROUBOURDEAU H; RIBAUD P; SOCIE G; RICHARD P; SELIMI F; HIRSCH I; GLUCKMAN E
      PROGRESS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Nouvelle revue francaise d'hematologie
    58. ALGAZI M; ANCELLEPARK R; ASJO B; BARIN F; BARME M; BARRESINOUSSI F; BAYLON H; BENICHOU J; BENICHOU G; BEZEAUD A; BLANCHER A; BLATTNER WA; BLOT P; BOURROUILLOU G; BOUTTIER D; BOVEN B; BRUNET JB; CADROY Y; CAEN J; CAHAN C; CALVAS P; CARANOBE C; CARRELL RW; CHANZY M; CHAOUAT G; CHIODI F; COLOMBIES P; COUTINHO A; DAUSSET J; DEVINCENTI I; DEBRE P; DENIS F; DESMYTER J; DEUBEL V; DEVERGIE A; DODIN A; DORE JF; DREYFUS JC; DREYFUSBRISAC C; DUCOS J; DURAND H; FENYO EM; FLEURY H; FOURNEL JJ; FROTTIER J; GAILLARD J; GALANAUD P; GARCON P; GAZZOLO L; GEORGES AJ; GEORGESCOURBOT MC; GIRARD M; GLUCKMAN E; GLUCKMAN JC; GOLDBERG M; GOUBAU P; GUILLIN MC; HERRAULT A; JENNINGS M; JUHANVAGUE I; KANKI PJ; KAZATCHKINE M; KIRN A; KLATZMANN D; KOHEN JP; KREIS H; KRUH J; LEMINOR L; LESOURD G; LIDEREAU R; LORTHOLARY P; LOWENSTEIN W; LOYGUE J; MARCOVICH H; MARTY M; MATHIOT C; MONODBROCA P; ORTH G; DASILVA LP; PERES G; PILLOT J; POLICARD C; REYNES J; ROZENBAUM W; SCARLATTI G; SCHAISON G; SCHUPBACH J; SIE P; SMILOVICI W; SOURNIA JC; TARANTOLA D; TAVITIAN A; TEDGUI A; TESTAS P; TIOLLAIS P; ULLMAN A; WOLLMAN E; WOLLMAN A
      APPEAL TO MITTERRAND IN BLOOD SCANDAL

      Nature
    59. SOCIE G; SELIMI F; SEDEL L; FRIJA J; DEVERGIE A; BOURDEAU HE; RIBAUD P; GLUCKMAN E
      AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL FINDINGS, INCIDENCE AND RISK-FACTORS

      British Journal of Haematology
    60. DEVERGIE A; LABOPIN M; APPERLEY J; CARRERAS E; PRENTICE G; HERSTENSTEIN B; REIFFERS J; MICHALLET M; JACOBSEN N; JOUET JP; GOLDMAN J; VANBIEZEN A; GRATWOHL A
      EUROPEAN RESULTS OF 357 MATCHED UNRELATED DONOR (MUD) TRANSPLANTS FORCHRONIC MYELOID-LEUKEMIA (CML) - IMPACT OF HLAD SUBTYPES ANALYSIS

      Blood
    61. GRATWOHL A; HERMANS J; APPERLEY J; ARCESE W; BACIGULAPO A; BANDINI G; BOOGAERTS M; BOSI A; CARRERAS E; DEVERGIE A; FERRANT A; FIBBE WE; FRASSONI F; GAHRTON G; GOLDMAN J; IRIONDO A; JACOBSEN N; LINK H; KOLB HJ; MICHALLET M; PRENTICE HG; REIFFERS J; VANRHEE F; RUUTU T; TORLONTANO G; SCHWEIKOFER H; VERNANT JP; DEWITTE T; NIEDERWIESER D
      ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CML

      Blood
    62. JANIN A; SOCIE G; DEVERGIE A; ARACTINGI S; ESPEROU H; VEROLA MO; GLUCKMAN E
      FASCIITIS IN CHRONIC GRAFT-VERSUS-HOST DISEASE - A CLINICOPATHOLOGICAL STUDY OF 14 CASES

      Annals of internal medicine
    63. SAHMOUD TM; HEUDES D; IRINOPOULOU T; GLUCKMAN E; NGUYEN Q; BROCHERIOU C; DEVERGIE A; RIGAUT JP; MARY JY
      TOWARDS AN OBJECTIVE PROGNOSTIC INDEX OF ACUTE GRAFT-VERSUS-HOST DISEASE

      Analytical cellular pathology
    64. PIGNEUX A; REIFFERS J; DEVERGIE A; LAFAGE M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; GUILHOT F; GLUCKMAN E
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    65. DEVERGIE A; GIRINSKY T; SOCIE G; ACHOR S; GLUCKMAN E
      CHRONIC GRAFT-VERSUS-HOST DISEASE TREATED WITH THORACO ABDOMINAL IRRADIATION

      Experimental hematology
    66. SUTTON L; KUENTZ M; CORDONNIER C; BLAISE D; DEVERGIE A; GUYOTAT D; LEBLOND V; FLESCH M; BORDIGONI P; ATTAL M; REIFFERS J; IFRAH N; MILPIED N; GRATECOS N; CAILLOT D; TROUSSARD X; BELANGER C; FACON T; PICO JL; MICHALLET M; RIO B; LIOURE B; VERNANT JP
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - FACTORS PREDICTIVE OF TRANSPLANT-RELATED MORTALITY AND INFLUENCE OF TOTAL-BODY IRRADIATION MODALITIES

      Bone marrow transplantation
    67. GRATWOHL A; HERMANS J; NIEDERWIESER D; FRASSONI F; ARCESE W; GAHRTON G; BANDINI G; CARRERAS E; VERNANT JP; BOSI A; DEWITTE T; FIBBE WE; ZWAAN F; MICHALLET M; RUUTU T; DEVERGIE A; IRIONDO A; APPERLEY J; REIFFERS J; SPECK B; GOLDMAN J
      BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - LONG-TERM RESULTS

      Bone marrow transplantation
    68. SAUGIERVEBER P; DEVERGIE A; SULAHIAN A; RIBAUD P; TRAORE F; BOURDEAUESPEROU H; GLUCKMAN E; DEROUIN F
      EPIDEMIOLOGY AND DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN BONE-MARROW TRANSPLANT PATIENTS - RESULTS OF A 5-YEAR RETROSPECTIVE STUDY

      Bone marrow transplantation
    69. VEXIAU P; PEREZCASTIGLIONI P; SOCIE G; DEVERGIE A; TOUBERT ME; ARACTINGI S; GLUCKMAN E
      THE EUTHYROID SICK SYNDROME - INCIDENCE, RISK-FACTORS AND PROGNOSTIC VALUE SOON AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      British Journal of Haematology
    70. POL S; THIERS V; DRISS F; DEVERGIE A; BERTHELOT P; BRECHOT C; GLUCKMAN E
      LACK OF EVIDENCE FOR A ROLE OF HCV IN HEPATITIS-ASSOCIATED APLASTIC-ANEMIA

      British Journal of Haematology
    71. ARACTINGI S; SOCIE G; DEVERGIE A; DUBERTRET L; GLUCKMAN E
      LOCALIZED SCLERODERMA-LIKE LESIONS ON THE LEGS IN BONE-MARROW TRANSPLANT RECIPIENTS - ASSOCIATION WITH POLYNEUROPATHY IN THE SAME DISTRIBUTION

      British journal of dermatology
    72. SOCIE G; GLUCKMAN E; RAYNAL B; PETIT T; LANDMAN J; DEVERGIE A; BRISON O
      BONE-MARROW TRANSPLANTATION FOR FANCONI-ANEMIA USING LOW-DOSE CYCLOPHOSPHAMIDE THORACOABDOMINAL IRRADIATION AS CONDITIONING REGIMEN - CHIMERISM STUDY BY THE POLYMERASE CHAIN-REACTION

      Blood
    73. STARK RA; RICHARD P; DEVERGIE A; GALIBERT F; GLUCKMAN E
      MINIMAL RESIDUAL DISEASE DETECTED BY THE PCR IN CHRONIC MYELOID-LEUKEMIA - COMPARISON OF CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION AND BUSULFAN-CYCLOPHOSPHAMIDE BONE-MARROW TRANSPLANTATION CONDITIONING

      Acta haematologica
    74. DEVERGIE A; SOCIE G; ESPEROUBOURDEAU H; RIBAUD P; TRAINEAU R; GLUCKMAN E
      INFLUENCE OF VARIOUS CONDITIONING REGIMENS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION FOR LEUKEMIA

      Nouvelle revue francaise d'hematologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 04:57:54